Promising evidence for Ginkgo biloba in Alzheimer's disease
Published 13 November 2007
The biggest ever comprehensive review on the use of Ginkgo biloba for the treatment of dementia has been published by the Alzheimer's Society and the Cochrane Collaboration.
The systematic review, which identified 33 previous clinical trials of Ginkgo, dating back to 1976, provides promising evidence that taking Ginkgo biloba can improve memory and overall function for people with dementia.
For more information see the Cochrane Collaboration website:
http://www.cochrane.org/.
New clinical trial on Ginkgo biloba
The findings of the Cochrane review provided the green light for a major clinical trial of Ginkgo in people with early dementia who are looked after by their GP.
The new study, supported by more than £¼ million from the Alzheimer's Society and jointly run by Imperial College and the Royal London Homeopathic Hospital, studies 400 people with dementia, following them over a period of six months while they receive treatment either with Ginkgo or a placebo.
